These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 23110159)

  • 1. ReFlexIn: a flexible receptor protein-ligand docking scheme evaluated on HIV-1 protease.
    Leis S; Zacharias M
    PLoS One; 2012; 7(10):e48008. PubMed ID: 23110159
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficient inclusion of receptor flexibility in grid-based protein-ligand docking.
    Leis S; Zacharias M
    J Comput Chem; 2011 Dec; 32(16):3433-9. PubMed ID: 21919015
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A method for biomolecular structural recognition and docking allowing conformational flexibility.
    Sandak B; Nussinov R; Wolfson HJ
    J Comput Biol; 1998; 5(4):631-54. PubMed ID: 10072081
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ensemble docking of multiple protein structures: considering protein structural variations in molecular docking.
    Huang SY; Zou X
    Proteins; 2007 Feb; 66(2):399-421. PubMed ID: 17096427
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficient molecular docking of NMR structures: application to HIV-1 protease.
    Huang SY; Zou X
    Protein Sci; 2007 Jan; 16(1):43-51. PubMed ID: 17123961
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Integrating Multiple Receptor Conformation Docking and Multi Dimensional QSAR for Enhancing Accuracy of Binding Affinity Prediction.
    Radhika V; Jaraf HA; Kanth SS; Vijjulatha M
    Curr Comput Aided Drug Des; 2017; 13(2):127-142. PubMed ID: 28103770
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protein flexibility in ligand docking and virtual screening to protein kinases.
    Cavasotto CN; Abagyan RA
    J Mol Biol; 2004 Mar; 337(1):209-25. PubMed ID: 15001363
    [TBL] [Abstract][Full Text] [Related]  

  • 8. GalaxyDock: protein-ligand docking with flexible protein side-chains.
    Shin WH; Seok C
    J Chem Inf Model; 2012 Dec; 52(12):3225-32. PubMed ID: 23198780
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A scalable and accurate method for classifying protein-ligand binding geometries using a MapReduce approach.
    Estrada T; Zhang B; Cicotti P; Armen RS; Taufer M
    Comput Biol Med; 2012 Jul; 42(7):758-71. PubMed ID: 22658682
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Using AutoDock for ligand-receptor docking.
    Morris GM; Huey R; Olson AJ
    Curr Protoc Bioinformatics; 2008 Dec; Chapter 8():Unit 8.14. PubMed ID: 19085980
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular docking and 3D-QSAR studies of HIV-1 protease inhibitors.
    Khedkar VM; Ambre PK; Verma J; Shaikh MS; Pissurlenkar RR; Coutinho EC
    J Mol Model; 2010 Jul; 16(7):1251-68. PubMed ID: 20069323
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Incorporating protein flexibility in structure-based drug discovery: using HIV-1 protease as a test case.
    Meagher KL; Carlson HA
    J Am Chem Soc; 2004 Oct; 126(41):13276-81. PubMed ID: 15479081
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Generation of receptor structural ensembles for virtual screening using binding site shape analysis and clustering.
    Osguthorpe DJ; Sherman W; Hagler AT
    Chem Biol Drug Des; 2012 Aug; 80(2):182-93. PubMed ID: 22515569
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In pursuit of virtual lead optimization: pruning ensembles of receptor structures for increased efficiency and accuracy during docking.
    Bolstad ES; Anderson AC
    Proteins; 2009 Apr; 75(1):62-74. PubMed ID: 18781587
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predicting structural effects in HIV-1 protease mutant complexes with flexible ligand docking and protein side-chain optimization.
    Schaffer L; Verkhivker GM
    Proteins; 1998 Nov; 33(2):295-310. PubMed ID: 9779795
    [TBL] [Abstract][Full Text] [Related]  

  • 16. BP-Dock: a flexible docking scheme for exploring protein-ligand interactions based on unbound structures.
    Bolia A; Gerek ZN; Ozkan SB
    J Chem Inf Model; 2014 Mar; 54(3):913-25. PubMed ID: 24380381
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exploring experimental sources of multiple protein conformations in structure-based drug design.
    Damm KL; Carlson HA
    J Am Chem Soc; 2007 Jul; 129(26):8225-35. PubMed ID: 17555316
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Distinguishing binders from false positives by free energy calculations: fragment screening against the flap site of HIV protease.
    Deng N; Forli S; He P; Perryman A; Wickstrom L; Vijayan RS; Tiefenbrunn T; Stout D; Gallicchio E; Olson AJ; Levy RM
    J Phys Chem B; 2015 Jan; 119(3):976-88. PubMed ID: 25189630
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular recognition of the inhibitor AG-1343 by HIV-1 protease: conformationally flexible docking by evolutionary programming.
    Gehlhaar DK; Verkhivker GM; Rejto PA; Sherman CJ; Fogel DB; Fogel LJ; Freer ST
    Chem Biol; 1995 May; 2(5):317-24. PubMed ID: 9383433
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development, validation, and applications of anisotropic polarizable molecular mechanics to study ligand and drug-receptor interactions.
    Gresh N
    Curr Pharm Des; 2006; 12(17):2121-58. PubMed ID: 16796560
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.